Medtronic (Ireland) has entered into a partnership with the Chengdu municipal government (Sichuan province, China) to manufacture and deploy advanced diabetes therapies in the city. Under the agreement, Medtronic will invest an undisclosed amount in a manufacturing plant to produce sensor augmented pump systems for diabetes management. In addition, Medtronic plans to enter into a partnership with the Chengdu government to allow people with diabetes in Sichuan province to access the device.